Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the ...

Depending on your source of health news or the slant of your social media feed, you might be getting inundated these days with info about peptide therapy. This medical treatment involves using ...

CeSPIACE is a short peptide made up of natural amino acids. It forms a two-helix bundle, which then self-assembles into a ...

Peptides are essentially molecules of amino acids that are rich in protein. Although the body makes its own peptides -- more than 7,000 of them -- which are necessary for a whole slew of different ...

The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.